US 10207013
Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI
granted A61KA61K49/106A61K49/108
Quick answer
US patent 10207013 (Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI) held by The Board of Regents of the University of Texas System expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K49/106, A61K49/108